Genetic testing for melanoma

Lancet Oncology

Volumn 3, Issue 11, 2002, Pages 653-654

  Kefford, Richard ^a   Bishop, Julia Newton ^a   Tucker, Margaret ^a   Paillerets, Brigitte Bressac De ^a   Bianchi Scarrá, Giovanna ^a   Bergman, Wilma ^a   Goldstein, Alisa ^a   Puig, Susana ^a   Mackie, Rona ^a   Elder, David ^a   Hansson, Johan ^a   Hayward, Nicholas ^a   Hogg, David ^a   Olsson, Håkan ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P14ARF; PROTEIN P16;

ARTICLE; CANCER INCIDENCE; CANCER SCREENING; CONTROLLED STUDY; DISEASE MARKER; FAMILY HISTORY; GENE MUTATION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GERM LINE; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; INHERITANCE; MELANOMA; PHENOTYPE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SELF EXAMINATION;

EID: 0036847390     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(02)00894-X     Document Type: Letter

References (10)

1. Kefford RF, Newton Bishop JA, Bergman W, Tucker MA. Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: a consensus statement of the Melanoma Genetics Consortium. J Clin Oncol 1999; 17: 3245-51.
2. Bishop DT, Demenais F, Goldstein GM, et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 2002; 94: 894-903.
3. Goldstein AM, Martinez M, Tucker MA, Demenais F. Gene-covariate interaction between dysplastic nevi and the CDKN2A gene in American melanoma-prone families. Cancer Epidemiol Biomarkers Prev 2000; 9: 889-94.
4. Bishop JA, Wachsmuth RC, Harland M, et al. Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations. J Invest Dermatol 2000; 114: 28-33.
5. Aitken J, Welch J, Duffy D, et al. CDKN2A variants in a population-based sample of Queensland families with melanoma. J Natl Cancer Inst 1999; 91: 446-52.
6. Holland EA, Beaton SC, Becker TM, et al. Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds. Oncogene 1995; 11: 2289-94.
7. Gruis NA, van der Velden PA, Sandkuijl LA, et al. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat Genet 1995; 10: 351-53.
8. Goldstein AM, Struewing JP, Chidambaram A, et al. Genotype-phenotype relationships in US melanoma-prone families with CDKN2A and CDK4 mutations. J Natl Cancer Inst 2000; 92: 1006-10.
9. Ciotti P, Struewing JP, Mantelli M, et al. A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families. Am J Hum Genet 2000; 67: 311-19.
10. Ghiorzo P, Ciotti P, Mantelli M, et al. Characterization of Ligurian melanoma families and risk of occurrence of other neoplasia. Int J Cancer 1999; 83: 441-48.